Photo by luismmolina/iStock via Getty Images
Without deviation from the norm, progress is not possible.” ― Frank Zappa
Today we take an in-depth look at a small developmental firm whose shares have rocketed up so far in 2021. A full analysis follows below.
Company Overview:
GT Biopharma, Inc. (GTBP) is a Beverley Hills-based biotech concern focused on the development of immuno-therapeutic products with an initial focus on oncology. The company has one asset undergoing evaluation in a Phase 1/2…

Click here to view the original article.